🇺🇸 FDA
Pipeline program

phosphate-buffered saline for SC administration

ALN-6400-001

Phase 2 small_molecule active

Quick answer

phosphate-buffered saline for SC administration for Hereditary Hemorrhagic Telangiectasia (HHT) is a Phase 2 program (small_molecule) at Alnylam Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Alnylam Netherlands B.V.
Indication
Hereditary Hemorrhagic Telangiectasia (HHT)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials